09:21 AM EDT, 06/10/2026 (MT Newswires) -- Healthcare stocks were mixed premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF ( XLV ) slightly higher and the iShares Biotechnology ETF (IBB) down 0.2%.

Sanofi ( SNY ) stock was down more than 2% after the company said it will discontinue a phase 3 trial of its experimental drug riliprubart in patients with a type of chronic inflammatory demyelinating polyneuropathy after an interim review found the study was unlikely to provide sufficient efficacy.

Pulse Biosciences ( PLSE ) shares were down more than 4% after the company said it will issue a redemption notice to retire the remaining 200% common stock warrants from its July 2024 rights offering.

Tango Therapeutics ( TNGX ) stock was down more than 1% after the company said it priced an underwritten public offering of 18.2 million common shares and pre-funded warrants to purchase up to 1.8 million additional shares.